In Vitro Human Cancer Models for Biomedical Applications.
biomedical applications
cancer markers
human cancers
in vitro model
therapeutic development
tumor biology
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
03 May 2022
03 May 2022
Historique:
received:
17
03
2022
revised:
16
04
2022
accepted:
30
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
15
5
2022
Statut:
epublish
Résumé
Cancer is one of the leading causes of death worldwide, and its incidence is steadily increasing. Although years of research have been conducted on cancer treatment, clinical treatment options for cancers are still limited. Animal cancer models have been widely used for studies of cancer therapeutics, but these models have been associated with many concerns, including inaccuracy in the representation of human cancers, high cost and ethical issues. Therefore, in vitro human cancer models are being developed quickly to fulfill the increasing demand for more relevant models in order to get a better knowledge of human cancers and to find novel treatments. This review summarizes the development of in vitro human cancer models for biomedical applications. We first review the latest development in the field by detailing various types of in vitro human cancer models, including transwell-based models, tumor spheroids, microfluidic tumor-microvascular systems and scaffold-based models. The advantages and limitations of each model, as well as their biomedical applications, are summarized, including therapeutic development, assessment of tumor cell migration, metastasis and invasion and discovery of key cancer markers. Finally, the existing challenges and future perspectives are briefly discussed.
Identifiants
pubmed: 35565413
pii: cancers14092284
doi: 10.3390/cancers14092284
pmc: PMC9099454
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Int J Dev Biol. 2004;48(5-6):563-71
pubmed: 15349831
APL Bioeng. 2021 Jan 21;5(1):010902
pubmed: 33532672
Biofabrication. 2020 Jul 29;12(4):045014
pubmed: 32599574
Gastroenterology. 2018 Mar;154(4):1066-1079.e5
pubmed: 29113809
Biofabrication. 2018 Sep 10;10(4):044102
pubmed: 30129928
Mutat Res. 2013 Jan-Mar;752(1):10-24
pubmed: 22940039
Front Pharmacol. 2018 Jan 23;9:6
pubmed: 29410625
Front Immunol. 2021 May 03;12:639572
pubmed: 34012434
Oncotarget. 2016 Oct 25;7(43):69816-69828
pubmed: 27634879
Annu Rev Pathol. 2020 Jan 24;15:123-147
pubmed: 31530089
Biomed Microdevices. 2008 Apr;10(2):197-202
pubmed: 17965938
Cancer Res. 2016 Apr 15;76(8):2465-77
pubmed: 26896279
Expert Opin Drug Discov. 2021 Aug;16(8):841-850
pubmed: 33823728
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Front Mol Biosci. 2020 Mar 06;7:33
pubmed: 32211418
Anticancer Res. 2009 Apr;29(4):1255-62
pubmed: 19414372
Int J Biol Macromol. 2021 Aug 31;185:604-619
pubmed: 34216662
Commun Biol. 2021 Jul 21;4(1):893
pubmed: 34290356
Oncol Rep. 2015 Apr;33(4):1837-43
pubmed: 25634491
Cancers (Basel). 2021 Feb 19;13(4):
pubmed: 33669619
Int J Mol Sci. 2020 Aug 28;21(17):
pubmed: 32872135
Bioengineering (Basel). 2020 Dec 22;8(1):
pubmed: 33375053
Acta Biomater. 2017 Mar 1;50:271-279
pubmed: 28011141
Biomaterials. 2014 Feb;35(7):2264-71
pubmed: 24360576
Adv Drug Deliv Rev. 2016 Feb 1;97:250-9
pubmed: 26571106
J Photochem Photobiol B. 2019 Apr;193:148-154
pubmed: 30884284
Adv Mater. 2019 Mar;31(10):e1806899
pubmed: 30663123
Bioact Mater. 2021 Feb 15;6(9):2767-2782
pubmed: 33665508
J Vis Exp. 2011 May 06;(51):
pubmed: 21587162
Nat Cell Biol. 2007 Dec;9(12):1392-400
pubmed: 18037882
Trends Biotechnol. 2015 Sep;33(9):504-13
pubmed: 26216543
Cancer Gene Ther. 2014 May;21(5):181-7
pubmed: 24787239
ACS Biomater Sci Eng. 2021 Nov 8;7(11):5288-5300
pubmed: 34661396
Lab Chip. 2015 Nov 21;15(22):4242-55
pubmed: 26364747
Int J Mol Sci. 2020 Apr 23;21(8):
pubmed: 32340319
Materials (Basel). 2019 Apr 22;12(8):
pubmed: 31013621
Sci Rep. 2020 Feb 17;10(1):2708
pubmed: 32066783
Oncol Lett. 2017 Dec;14(6):6999-7010
pubmed: 29344128
J Mater Sci Mater Med. 2019 Oct 10;30(10):115
pubmed: 31599365
J Cell Sci. 2017 Jan 1;130(1):203-218
pubmed: 27663511
Anticancer Res. 2006 Sep-Oct;26(5A):3393-401
pubmed: 17094458
Am J Transl Res. 2014 Jan 15;6(2):114-8
pubmed: 24489990
Theranostics. 2021 Jan 1;11(2):941-957
pubmed: 33391514
Mater Today Bio. 2019 May 25;1:100008
pubmed: 32159140
Sci Rep. 2016 Jan 11;6:19103
pubmed: 26752500
Cancer Cell. 2012 Jan 17;21(1):66-81
pubmed: 22264789
Cells. 2019 Sep 14;8(9):
pubmed: 31540045
Tissue Cell. 2019 Jun;58:33-41
pubmed: 31133244
Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):214-9
pubmed: 25524628
Oncotarget. 2017 Dec 22;9(4):4935-4950
pubmed: 29435153
Sci Transl Med. 2015 Aug 19;7(301):301ra130
pubmed: 26290412
PLoS One. 2012;7(1):e29923
pubmed: 22253826
Trends Cancer. 2021 Mar;7(3):249-264
pubmed: 33218948
J Pharm Pharm Sci. 2005 Sep 28;8(3):536-43
pubmed: 16401399
SLAS Discov. 2022 Jan;27(1):39-54
pubmed: 35058175
Methods Mol Med. 2007;140:141-51
pubmed: 18085207
Sci Adv. 2021 Aug 18;7(34):
pubmed: 34407932
Oncol Rep. 2010 Nov;24(5):1147-51
pubmed: 20878104
Biomicrofluidics. 2016 Jan 06;10(1):014101
pubmed: 26858813
Nat Protoc. 2009;4(3):309-24
pubmed: 19214182
JCI Insight. 2020 Aug 6;5(15):
pubmed: 32614802
Oncotarget. 2015 Nov 3;6(34):36603-14
pubmed: 26474384
Sci Rep. 2018 Mar 15;8(1):4608
pubmed: 29545552
Acta Biomater. 2021 Nov;135:234-242
pubmed: 34389482
Lab Chip. 2021 Oct 26;21(21):4155-4165
pubmed: 34515264
Clin Exp Metastasis. 2008;25(5):549-57
pubmed: 18386134
Int J Mol Sci. 2021 Mar 02;22(5):
pubmed: 33801273
Mol Pharm. 2012 Nov 5;9(11):3171-82
pubmed: 22946843
Int J Oncol. 2018 Jun;52(6):1787-1800
pubmed: 29568859
Biotechnol Bioeng. 2003 Jul 20;83(2):173-80
pubmed: 12768623
Cell Rep. 2019 Jan 15;26(3):608-623.e6
pubmed: 30650355
Cell. 2018 Sep 6;174(6):1586-1598.e12
pubmed: 30100188
Anal Chim Acta. 2017 Jul 25;978:1-9
pubmed: 28595721
Biomaterials. 2016 Apr;84:76-85
pubmed: 26826297
Front Bioeng Biotechnol. 2021 Jun 22;9:682498
pubmed: 34239860
ACS Biomater Sci Eng. 2021 Mar 8;7(3):1230-1241
pubmed: 33586426
Small. 2010 Aug 16;6(16):1794-805
pubmed: 20623530
Adv Sci (Weinh). 2021 Jun;8(11):e2004856
pubmed: 34105271
Curr Opin Cell Biol. 2010 Oct;22(5):697-706
pubmed: 20822891
Biofabrication. 2019 Jun 26;11(3):034102
pubmed: 31141796
ACS Appl Bio Mater. 2020 Sep 21;3(9):5552-5573
pubmed: 35021789
Int J Mol Sci. 2021 Sep 18;22(18):
pubmed: 34576261
Cancer Res. 2014 Sep 1;74(17):4937-45
pubmed: 24970480
Photochem Photobiol. 2000 Jul;72(1):128-34
pubmed: 10911737
Sci Adv. 2018 Apr 27;4(4):eaas8998
pubmed: 29719868
Adv Drug Deliv Rev. 2021 Aug;175:113760
pubmed: 33838208
Nat Phys. 2020 Jan;16(1):101-108
pubmed: 32905405
Mol Cancer Ther. 2005 Mar;4(3):399-412
pubmed: 15767549
J Natl Cancer Inst. 2019 Mar 1;111(3):272-282
pubmed: 29860390
Biomaterials. 2020 Jan;229:119547
pubmed: 31710953
J Cell Sci. 2021 Aug 1;134(15):
pubmed: 34374417
Nat Mater. 2012 Sep;11(9):768-74
pubmed: 22751181
Talanta. 2021 Jan 15;222:121525
pubmed: 33167235
Mol Pharm. 2020 Aug 3;17(8):2882-2890
pubmed: 32584586
J Cell Biol. 2017 Nov 6;216(11):3509-3520
pubmed: 28931556
Biomaterials. 2019 Apr;198:63-77
pubmed: 30098794
Trends Cancer. 2016 Jan 1;2(1):6-19
pubmed: 26858990
Cancer Metastasis Rev. 2021 Mar;40(1):71-88
pubmed: 33156478
Lab Chip. 2021 Jun 15;21(12):2306-2329
pubmed: 34085677
Nat Commun. 2014 Mar 25;5:3472
pubmed: 24668028
Biofabrication. 2014 Mar;6(1):015009
pubmed: 24589876
JCI Insight. 2021 Jun 22;6(12):
pubmed: 34003803
Theranostics. 2015 Apr 06;5(7):772-86
pubmed: 25897341
Biomaterials. 2019 May;202:35-44
pubmed: 30836243
Biofabrication. 2017 Jun 07;9(2):021002
pubmed: 28589925
Biotechnol Bioeng. 2019 Jan;116(1):206-226
pubmed: 30367820
J Control Release. 2012 Dec 10;164(2):192-204
pubmed: 22613880
J Clin Invest. 2018 Jun 1;128(6):2376-2388
pubmed: 29708513
Front Bioeng Biotechnol. 2016 Feb 12;4:12
pubmed: 26904541
J R Soc Interface. 2017 Jun;14(131):
pubmed: 28637915
ACS Biomater Sci Eng. 2018 Dec 10;4(12):4401-4411
pubmed: 33418833
PLoS One. 2020 Jan 16;15(1):e0220019
pubmed: 31945053
Int J Mol Sci. 2021 Jul 30;22(15):
pubmed: 34361000
Nat Rev Clin Oncol. 2017 Jan;14(1):45-56
pubmed: 27725680
Oncotarget. 2016 Jul 5;7(27):41948-41958
pubmed: 27248825
Microsyst Nanoeng. 2020 Jun 29;6:52
pubmed: 34567663
Molecules. 2019 Jul 10;24(14):
pubmed: 31295864
Front Bioeng Biotechnol. 2020 Apr 09;8:322
pubmed: 32328489
Adv Healthc Mater. 2019 Mar;8(5):e1900001
pubmed: 30734529
Biomaterials. 2006 Mar;27(8):1496-506
pubmed: 16243393
Sci Rep. 2019 May 8;9(1):7103
pubmed: 31068603
Lab Chip. 2019 Jan 29;19(3):369-386
pubmed: 30644496
Cell Cycle. 2017 Jan 2;16(1):73-81
pubmed: 27841696
Anal Chem. 2014 Mar 18;86(6):2997-3004
pubmed: 24568664
Biofabrication. 2020 Dec 31;13(1):
pubmed: 33126227
Cell Rep. 2019 Apr 23;27(4):1265-1276.e4
pubmed: 31018139
ACS Biomater Sci Eng. 2018 Feb 12;4(2):294-301
pubmed: 29457129
Front Immunol. 2020 Dec 10;11:603640
pubmed: 33362787
Cancer Lett. 2021 Jun 28;508:47-58
pubmed: 33766751
Mol Cancer. 2019 Mar 30;18(1):64
pubmed: 30927925
Mol Cancer Ther. 2006 Nov;5(11):2606-12
pubmed: 17088437
Lab Chip. 2019 Sep 7;19(17):2822-2833
pubmed: 31360969
J Control Release. 2018 May 10;277:1-13
pubmed: 29501721
J Exp Clin Cancer Res. 2020 May 1;39(1):75
pubmed: 32357910